|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frauenfelder T, Puhan MA, Lazor R, von
Garnier C, Bremerich J, Niemann T, Christe A, Montet X, Gautschi O,
Weder W, et al: Early detection of lung cancer: A statement from an
expert panel of the Swiss university hospitals on lung cancer
screening. Respiration. 87:254–264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Naimi AI, Cole SR, Hudgens MG and
Richardson DB: Estimating the effect of cumulative occupational
asbestos exposure on time to lung cancer mortality: Using
structural nested failure-time models to account for healthy-worker
survivor bias. Epidemiology. 25:246–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
El-Basmy A: Profile of lung cancer in
Kuwait. Asian Pac J Cancer Prev. 14:6181–6184. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li Y, Dai M, Chen Y, Zhang S, Chen W, Dai
Z and Zou X: Estimates of lung cancer mortality at the province
level in China. Zhongguo Fei Ai Za Zhi. 14:120–126. 2011.(In
Chinese). PubMed/NCBI
|
|
6
|
Ellis J: The impact of lung cancer on
patients and carers. Chron Respir Dis. 9:39–47. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Subirana M, Lopez C and Pascual A:
Non-invasive interventions for improving well-being and quality of
life in patients with lung cancer. Clin J Oncol Nurs. 14:81–82.
2012.
|
|
8
|
Zheng R, Zeng H, Zhang S, Fan Y, Qiao Y,
Zhou Q and Chen W: Lung cancer incidence and mortality in China,
2010. Thorac Cancer. 5:330–336. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han R, Zheng R, Zhang S, Wu M and Chen W:
Trend analyses on the differences of lung cancer incidence between
gender, area and average age in China during 1989–2008. Zhongguo
Fei Ai Za Zhi. 16:445–451. 2013.(In Chinese). PubMed/NCBI
|
|
10
|
Chen W, Zhang S and Zou X: Evaluation on
the incidence, mortality and tendency of lung cancer in China.
Thorac Cancer. 1:35–40. 2010. View Article : Google Scholar
|
|
11
|
NSCLC Meta-analysis Collaborative Group:
Preoperative chemotherapy for non-small-cell lung cancer: A
systematic review and meta-analysis of individual participant data.
Lancet. 383:1561–1571. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bambang IF, Lu D, Li H, Chiu LL, Lau QC,
Koay E and Zhang D: Cytokeratin 19 regulates endoplasmic reticulum
stress and inhibits ERp29 expression via p38 MAPK/XBP-1 signaling
in breast cancer cells. Exp Cell Res. 315:1964–1974. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rao GW and Hu WX: Synthesis, X-ray
crystallographic analysis, and antitumor activity of
1-acyl-3,6-disubstituted phenyl-1,4-dihydro-1,2,4,5-tetrazines.
Bioorg Med Chem Lett. 15:3174–3176. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Rao GW and Hu WX: Synthesis, structure
analysis, and antitumor activity of
3,6-disubstituted-1,4-dihydro-1,2,4,5-tetrazine derivatives. Bioorg
Med Chem Lett. 16:3702–3705. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou YL, Lü YP, Hu WX, Qiu LN, Wang WS,
Liu JD and Wu JG: ZGDHu-1-inducing apoptosis of SHI-1 leukemia
cells and its molecular mechanism. Zhongguo Shi Yan Xue Ye Xue Za
Zhi. 15:483–489. 2007.(In Chinese). PubMed/NCBI
|
|
16
|
Qiu LN, Zhou YL, Wang ZN, Huang Q and Hu
WX: ZGDHu-1 promotes apoptosis of chronic lymphocytic leukemia
cells. Int J Oncol. 41:533–540. 2012.PubMed/NCBI
|
|
17
|
Xia J, Chen SF, Lv YP, Lu LN, Hu WX and
Zhou YL: ZGDHu-1 induces G2/M phase arrest and apoptosis
in Kasumi-1 cells. Mol Med Rep. 11:3398–3404. 2015.PubMed/NCBI
|
|
18
|
Zhou YL, Hu WX, Lü YP, Qiu LN, Wang WS,
Yang ZY, Liu JD and Rao GW: Effect of ZGDHu-1 on proliferation and
apoptosis of A549 cells in vitro and antitumor activity in vivo.
Yao Xue Xue Bao. 42:26–34. 2007.(In Chinese). PubMed/NCBI
|
|
19
|
Murray AW: Recycling the cell cycle:
Cyclins revisited. Cell. 116:221–234. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Graña X and Reddy EP: Cell cycle control
in mammalian cells: Role of cyclins, cyclin dependent kinases
(CDKs), growth suppressor genes and cyclin-dependent kinase
inhibitors (CKIs). Oncogene. 11:211–219. 1995.PubMed/NCBI
|
|
21
|
Chen T, Stephens PA, Middleton FK and
Curtin NJ: Targeting the S and G2 checkpoint to treat cancer. Drug
Discov Today. 17:194–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Riccardi C and Nicoletti I: Analysis of
apoptosis by propidium iodide staining and flow cytometry. Nat
Protoc. 1:1458–1461. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Shin DY, Kim GY, Hwang HJ, Kim WJ and Choi
YH: Diallyl trisulfide-induced apoptosis of bladder cancer cells is
caspase-dependent and regulated by PI3K/Akt and JNK pathways.
Environ Toxicol Pharmacol. 37:74–83. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tchoghandjian A, Jennewein C, Eckhardt I,
Momma S, Figarella-Branger D and Fulda S: Smac mimetic promotes
glioblastoma cancer stem-like cell differentiation by activating
NF-κB. Cell Death Differ. 21:735–747. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Krohn A, Ahrens T, Yalcin A, Plönes T,
Wehrle J, Taromi S, Wollner S, Follo M, Brabletz T, Mani SA, et al:
Tumor cell heterogeneity in Small Cell Lung Cancer (SCLC):
Phenotypical and functional differences associated with
Epithelial-Mesenchymal Transition (EMT) and DNA methylation
changes. PLoS One. 9:e1002492014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Stark GR and Taylor WR: Control of the
G2/M transition. Mol Biotechnol. 32:227–248. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen CY, Oliner JD, Zhan Q, Fornace AJ Jr,
Vogelstein B and Kastan MB: Interactions between p53 and MDM2 in a
mammalian cell cycle checkpoint pathway. Proc Natl Acad Sci USA.
91:2684–2688. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Abraham E: NF-kappaB activation. Crit Care
Med. 28(Suppl): N100–N104. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen F, Lu Y, Zhang Z, Vallyathan V, Ding
M, Castranova V and Shi X: Opposite effect of NF-kappa B and c-Jun
N-terminal kinase on p53-independent GADD45 induction by arsenite.
J Biol Chem. 276:11414–11419. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Karin M and Lin A: NF-kappaB at the
crossroads of life and death. Nat Immunol. 3:221–227. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jin X, Wang Z, Qiu L, Zhang D, Guo Z, Gao
Z, Deng C, Wang F, Wang S and Guo C: Potential biomarkers involving
IKK/RelA signal in early stage non-small cell lung cancer. Cancer
Sci. 99:582–589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang X, Chen W and Lin Y: Sensitization of
TNF-induced cytotoxicity in lung cancer cells by concurrent
suppression of the NF-kappaB and Akt pathways. Biochem Biophys Res
Commun. 355:807–812. 2007. View Article : Google Scholar : PubMed/NCBI
|
